Document is current
Any future updates will be listed below
-
Authors
Schiulaz, Astrid
Nordio, Giovanna
Giacomel, Alessio
Easmin, Rubaida
Bettinelli, Andrea
Selvaggi, Pierluigi
Williams, Steven
Turkheimer, Federico
Jauhar, Sameer
Howes, Oliver
Veronese, Mattia https://orcid.org/0000-0003-3562-0683
,
Angelescu, Ilinca
Bloomfield, Micheal
Bonoldi, Ilaria
Borgan, Faith
Dahoun, Tarik
D’Ambrosio, Enrico
Demjaha, Arsime
Donocik, Jecek
Egerton, Alice
Kaar, Stephen
Kim, Euitae
Kim, Seoyoung
Maccabe, James
Matthews, Julian
McCutcheon, Robert
McGuire, Philip
Nosarti, Chiara
Nour, Matthew
Rogdaki, Maria
Rutigliano, Grazia
Talbot, Peter S.
Vano, Luke
-
Funding
Funding for this research was provided by:
Wellcome Trust (215747/Z/19/Z)
NIHR Maudsley Biomedical Research Centre
Ministero dell’Istruzione, dell’Università e della Ricerca (CN00000013 CN1, PNC0000002_DARE, 2022RXM3H7)
- License Information
-
More Information
Article History
Received: 30 September 2024
Revised: 25 March 2025
Accepted: 23 April 2025
First Online: 5 May 2025
Declarations
:
: All research protocols for data acquisition were approved by local ethics committees and institutional review boards. Informed written consent was obtained for all participants and the studies were conducted following the Declaration of Helsinki and Good Clinical Practice.
: O.H. and M.V. hold a patent application for the use of dopamine imaging as a prognostic tool in mental health (WO2021111116). The other authors do not report any conflict of interest in relation to this article.
